Pages changed: GLP-Agonists and Insulin for Type 2 Diabetes
Brief mention made of the upcoming approval of semaglutide, the first GLP-1 agonist in pill form and of Fiasp, a new fast-acting insulin which is similar to Apidra in that it can be injected just after eating and still be effective.
No comments:
Post a Comment
Comments posted to promote products or services are deleted. Don't waste our time or yours posting them here.
Note: Only a member of this blog may post a comment.